技術(shù)外包服務(wù):

★骨形態(tài)發(fā)生抑制蛋白SOST抗體說明書 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等

★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。

實(shí)驗(yàn)流程：

骨形態(tài)發(fā)生抑制蛋白SOST抗體說明書 英文名稱  Anti-Sclerostin

中文名稱  骨形態(tài)發(fā)生抑制蛋白SOST抗體說明書 

別    名 BEER; Cortical hyperostosis with syndactyly; Sclerosteosis; Sclerostin; SOST; SOST_HUMAN; VBCH.

產(chǎn)品屬性：

濃    度  1mg/1ml

規(guī) 格  0.2ml/200μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep

產(chǎn)品類型   一抗  

研究領(lǐng)域    細(xì)胞生物 信號(hào)轉(zhuǎn)導(dǎo) 生長因子和激素

蛋白分子量  predicted molecular weight: 21kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated synthetic peptide derived from human Sclerostin

亞    型  IgG

純化方法   affinity purified by Protein A

儲(chǔ) 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

骨形態(tài)發(fā)生抑制蛋白SOST抗體說明書 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 Negative regulator of bone growth.Sclerostin (SOST) is a bone morphogenetic protein (BMP) antagonist, leading to the activation of BMP signaling. It negatively regulates the formation of bone by repressing the differentiation and/or function of osteoblasts induced by BMPs. It has been shown that Sclerostin binds BMP-5, -6, and -7 with high affinity and BMP-2 and -4 with low affinity. The noggin-sclerostin protein complex represents a novel mechanism for the fine-tuning of BMP activity in bone homeostasis. Evidence is accumulating that one of the important mechanisms of bone regulation by sclerostin is the modulation of Wnt/Beta-catenin signaling. Sclerostin also rapidly activated ERK-1/2 MAPK signaling, indicating the involvement of additional signaling pathways

Function : Negative regulator of bone growth that acts through inhibition of Wnt signaling and bone formation.

Subunit : Interacts with LRP4 (via the extracellular domain); the interaction facilitates the inhibition of Wnt signaling. Interacts with LRP5 (via the first two YWTD-EGF repeat domains); the interaction inhibits Wnt-mediated signaling. Interacts with LRP6.

Subcellular Location : Secreted.

Tissue Specificity : Widely expressed at low levels with highest levels in bone, cartilage, kidney, liver, bone marrow and primary osteeoblasts differentiated for 21 days.

DISEASE : Defects in SOST are the cause of sclerosteosis (SOST) [MIM:269500]; also known as cortical hyperostosis with syndactyly. SOST is an autosomal recessive sclerosing bone dysplasia characterized by a generalized hyperostosis and sclerosis leading to a markedly thickened skull, with mandible, ribs, clavicles and all long bones also being affected. Due to narrowing of the foramina of the cranial nerves, facial nerve palsy, hearing loss and atrophy of the optic nerves can occur. Sclerosteosis is clinically and radiologically very similar to van Buchem disease, mainly differentiated by hand malformations and a large stature in sclerosteosis patients.

Note=A 52 kb deletion downstream of SOST results in SOST transcription suppression and is a cause of van Buchem disease (VBCH) [MIM:239100]; also known as hyperostosis corticalis generalisata. VBCH is an autosomal recessive sclerosing bone dysplasia characterized by endosteal hyperostosis of the mandible, skull, ribs, clavicles, and diaphyses of the long bones. Affected patients present a symmetrically increased thickness of bones, most frequently found as an enlarged jawbone, but also an enlargement of the skull, ribs, diaphysis of long bones, as well as tubular bones of hands and feet. The clinical consequence of increased thickness of the skull include facial nerve palsy causing hearing loss, visual problems, neurological pain, and, very rarely, blindness as a consequence of optic atrophy. Serum alkaline phosphatase levels are elevated.

Similarity : Belongs to the sclerostin family. Contains 1 CTCK (C-terminal cystine knot-like) domain.

Database links : UniProtKB/Swiss-Prot: Q9BQB4.1

全、新、優(yōu)、品、好四大特點(diǎn)：

骨形態(tài)發(fā)生抑制蛋白SOST抗體說明書 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。

正在熱銷的相關(guān)產(chǎn)品：

MIP-1 Beta (macrophage inflammatory protein 1 Beta) 巨噬細(xì)胞因子1β 抗原Multi-class antibodies規(guī)格： 0.5mg

Anti-beta-Amyloid 1-40(CT) β淀粉樣肽 1-40 (C端)抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh phospho-Bid(Ser61) 磷酸化BH3結(jié)構(gòu)域凋亡誘導(dǎo)蛋白抗體 規(guī)格 0.1ml

品名 規(guī)格 備注

VCAM1 英文名稱： 內(nèi)皮細(xì)胞粘附分子抗體 0.1ml

DUSP22 英文名稱： 雙特異性磷酸酶22抗體 0.2ml

Anti-beta-Amyloid 1-40(CT) β淀粉樣肽 1-40 (C端)抗體Multi-class antibodies規(guī)格： 0.1ml

Anti-Phospho-PDGF Receptor beta (Tyr771)/FITC 熒光素標(biāo)記磷酸化血小板源性生長因子受體-B抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rabbit Anti-Goat IgM/FITC 熒光素標(biāo)記兔抗羊IgMMulti-class antibodies規(guī)格： 0.3ml

人瘤病毒16型E7抗體 Anti-E7 protein 0.1ml

Rabbit Anti-human IgM/PE-Cy7 PE-Cy7標(biāo)記的兔抗人IgM 0.1ml

FAM71D 英文名稱： FAM71D蛋白抗體 0.2ml

Rhesus antibody Rh phospho-TIRAP(Tyr86) 磷酸化白細(xì)胞介素1受體銜接蛋白抗體 規(guī)格 0.1ml

Rabbit Anti-Goat IgM/FITC 熒光素標(biāo)記兔抗羊IgMMulti-class antibodies規(guī)格： 0.3ml

SMURF1 英文名稱： Smad蛋白E3泛素連接酶1抗體 0.1ml

ELF1 英文名稱： 轉(zhuǎn)錄因子ELF1抗體 0.2ml

生精細(xì)胞凋亡相關(guān)基因3抗體 Anti-TSARG3 0.2ml

Anti-TREML1/TLT1/FITC 熒光素標(biāo)記兔抗人、大、小鼠髓系細(xì)胞觸發(fā)受體樣轉(zhuǎn)錄因子1抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh phospho-IRS1(Ser1101) 磷酸化受體底物-1抗體 規(guī)格 0.1ml

Secretin receptor 分泌素受體(抗原)Multi-class antibodies規(guī)格： 0.5mg

PC-12(高分化)，PC12，大鼠腎上腺髓質(zhì)嗜鉻瘤分化細(xì)胞株(高分化)

KM9304 EBV-轉(zhuǎn)化人淋巴細(xì)胞(彝族)

HA Others H1N1 甲型 H1N1 (A/Texas/05/2009) HA 人細(xì)胞裂解液 (陽性對(duì)照)

CM-H099人真皮淋巴上皮細(xì)胞完全培養(yǎng)基100mL

人肺泡上皮細(xì)胞HPAEpiC

人癌細(xì)胞;MDA-MB-231 人視網(wǎng)膜色素上皮細(xì)胞完全培養(yǎng)基 100mL

CL-0012A172(人腦細(xì)胞)5×106cells/瓶×2

ART3 Others Human 人 ART3 人細(xì)胞裂解液 (陽性對(duì)照)

心肌細(xì)胞生長添加物CMGS

ISK (Ishikawa)細(xì)胞，人細(xì)胞 小鼠小細(xì)胞,Bv-2細(xì)胞 心肌成纖維細(xì)胞Many types of cells包裝：5 × 105次方(1ml)

GH3(大鼠細(xì)胞) 5×106cells/瓶×2

HOB Pellet 人成骨細(xì)胞團(tuán)塊 > 1 mio.cells 人脈絡(luò)叢內(nèi)皮細(xì)胞總RNAHCPEC NA

骨形態(tài)發(fā)生抑制蛋白SOST抗體說明書 PC-12(高分化)，PC12，大鼠腎上腺髓質(zhì)嗜鉻瘤分化細(xì)胞株(高分化)

KM9304 EBV-轉(zhuǎn)化人淋巴細(xì)胞(彝族)

HA Others H1N1 甲型 H1N1 (A/Texas/05/2009) HA 人細(xì)胞裂解液 (陽性對(duì)照)

CM-H099人真皮淋巴上皮細(xì)胞完全培養(yǎng)基100mL

人肺泡上皮細(xì)胞HPAEpiC

人癌細(xì)胞;MDA-MB-231 人視網(wǎng)膜色素上皮細(xì)胞完全培養(yǎng)基 100mL